EUVIMEDEUVIMED entdecken
Zurückgezogene Publikation

RETRACTED: Poly (lactic‐co‐glycolic acid) ‐encapsulated Endostar ‐loaded calcium phosphate cement as anti‐tumor bone cement for the treatment of bone metastasis in lung cancer

QingHua Tian, Cong Tian, YingYing Lu, BiCong Yan, Kaixian Zhang, ChunGen Wu iD

Environmental Toxicology · 2025

DOI: 10.1002/tox.24166 ↗

Kurz gefasst

Zurückgezogene Publikation in der Zeitschrift Environmental Toxicology, 2025. Verfasst von QingHua Tian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicin…. Hauptthemen laut MEDLINE: Lung Neoplasms, Bone Neoplasms, Bone Cements, Polylactic Acid-Polyglycolic Acid Copolymer. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Natural Scientific Fund of China, Natural Fund from Shanghai Municipal Health Commission, Natural Fund from Shanghai Science and Technology Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is one of the most common malignant tumors in the world. In approximately 30%–40% of lung cancer patients, bone metastases ensues with osteolytic destruction. Worse still, intractable pain, pathological fracture, and nerve compression caused by bone metastases are currently the bottleneck of research, diagnosis, and treatment of lung cancer. Therefore, the present study aims at investigating the effectiveness of a new composite material made of calcium phosphate cement (CPC) and Endostar on repairing bone defects in vitro and in vivo. As indicated in results, the mechanical properties of CPC+Endostar and CPC+PLGA+Endostar do not differ from those of pure CPC. The PLGA‐embedded Endostar slow‐release microspheres were designed and prepared, and were combined with CPC. Poly (lactic‐co‐glycolic acid (PLGA) is a biodegradable polymer material in vivo, so the effect on its mechanical properties is negligible. CPC+Endostar and CPC+PLGA+Endostar have been proved to inhibit cell proliferation, promote apoptosis and block cell cycle in G2 phase; the expression levels of osteoclast‐related genes CXCL2, TGF‐β1, IGF‐1, IL‐6, and RANKL were significantly decreased while osteogenic ability and alkaline phosphatase activity observably enhanced. In vivo studies have revealed that the expression levels of TRAP, RANKL, and Caspase3 in CPC+PLGA+ENDO‐treated tumor tissues after 3 weeks were higher than those in other groups with the prolongation of animal treatment time, while the expression levels of OPN and BCL2 were lower than those in other groups. In hematoxylin and eosin and TUNEL staining, 3 weeks of CPC+PLGA+ENDO‐treatment yielded higher tissue necrosis and apoptosis than other groups; computed tomography and magnetic resonance imaging results showed the posterior edge bone damage reduced as a result of the CPC+PLGA+ENDO grafting in vertebral pedicle. Overall, the feasibility and reliability of CPC‐loaded Endostar in the treatment of bone metastasis in lung cancer were investigated in this study, so as to promote the basic research and treatment of bone metastasis in lung cancer and other malignant tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsBone NeoplasmsBone CementsPolylactic Acid-Polyglycolic Acid CopolymerCalcium PhosphatesAntineoplastic AgentsAnimalsHumansMiceMaleCell ProliferationApoptosis

Stichwörter der Autor:innen

Endostarbone metastasiscalcium phosphate cementlung cancerosteolytic destruction

Substanzen

Bone CementsPolylactic Acid-Polyglycolic Acid CopolymerCalcium Phosphatescalcium phosphateAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Diagnostic and Interventional Radiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Oncology, Tengzhou Central People's Hospital Affiliated to Jining Medical College, Tengzhou, China.

ORCID-Profile: ChunGen Wu

Förderung

  • National Natural Scientific Fund of China
  • Natural Fund from Shanghai Municipal Health Commission
  • Natural Fund from Shanghai Science and Technology Commission

Zitieren

APA

Tian, Q., Tian, C., Lu, Y., Yan, B., Zhang, K., & Wu, C. (2025). RETRACTED: Poly (lactic‐co‐glycolic acid) ‐encapsulated Endostar ‐loaded calcium phosphate cement as anti‐tumor bone cement for the treatment of bone metastasis in lung cancer. Environmental Toxicology. https://doi.org/10.1002/tox.24166

Vancouver

Tian Q, Tian C, Lu Y, Yan B, Zhang K, Wu C. RETRACTED: Poly (lactic‐co‐glycolic acid) ‐encapsulated Endostar ‐loaded calcium phosphate cement as anti‐tumor bone cement for the treatment of bone metastasis in lung cancer. Environmental Toxicology. 2025. doi:10.1002/tox.24166

BibTeX
@article{Tian2025,
  author = {Tian, QingHua and Tian, Cong and Lu, YingYing and Yan, BiCong and Zhang, Kaixian and Wu, ChunGen},
  title = {RETRACTED: Poly (lactic‐co‐glycolic acid) ‐encapsulated Endostar ‐loaded calcium phosphate cement as anti‐tumor bone cement for the treatment of bone metastasis in lung cancer},
  journal = {Environmental Toxicology},
  year = {2025},
  doi = {10.1002/tox.24166}
}
Kostenlos starten →